Summary

● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.


Strengths

● The prospective high growth for the next fiscal years is among the main assets of the company

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.

● Low profitability weakens the company.

● The company appears highly valued given the size of its balance sheet.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.